Manganese Dosage: 1.8-2.3mg AI, 11mg Limit — What Blows Past It

By Erin Rose · Updated July 20, 2026 · Methodology

Educational summary — not medical advice. Liver disease and long-term parenteral/enteral nutrition patients should not rely on the general-population UL and should not self-supplement manganese — see the toxicity page. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Why ordinary dietary intake already clears the AI

Manganese is genuinely essential, but the population-level food-intake data changes the framing before you even get to a product. Whole grains, nuts, legumes, tea, and leafy greens are the dominant dietary sources, and average adult dietary intake is commonly reported in the 2–6mg/day range depending on diet composition (tea and whole-grain-heavy diets run higher) — comfortably above the 1.8–2.3mg AI without any supplement (NIH ODS). The closest thing to a controlled human deficiency study, Friedman 1987, needed a deliberately manganese-restricted lab diet in seven young men to produce measurable effects — that is not a realistic free-living scenario, and it is the structural basis for the honest verdict on this cluster: most people do not need a standalone manganese supplement.

Why the UL is set for neurotoxicity, not GI upset

Many mineral upper limits exist because high intake causes gastrointestinal discomfort — an unpleasant but low-stakes ceiling. Manganese is different: the 11mg adult UL exists specifically because of manganism, a Parkinsonism-like neurotoxic syndrome documented in the occupational-exposure literature (Racette 2017, Baker 2015). That occupational literature describes inhalation exposure far above any oral-supplement level and should not be read as implying a retail product will cause manganism — but it is the reason the ceiling exists at all, which is worth knowing before treating the UL as a soft or arbitrary number. Full context on the toxicity page.

Liver disease and long-term parenteral nutrition: the UL doesn't apply

The standard 11mg UL assumes normal hepatic and biliary excretion, since manganese is cleared from the body primarily via bile. In liver disease (cirrhosis) or long-term parenteral or enteral nutrition (TPN), that excretion pathway is impaired or bypassed entirely, and manganese measurably accumulates in the brain — visible on MRI as pallidal T1 hyperintensity, with correlated neurological symptoms (Spahr 1996; Jin 2018; Abdalian 2013; Iinuma 2003 in pediatric home-PN patients). This is the single most clinically important safety carve-out in this cluster: anyone in this situation should not self-supplement manganese or use the general-population UL as a safety reference — dosing must be managed by their clinical team.

How to take it

• Confirm you actually need it first. If you eat a normal diet, food almost certainly already covers the AI several times over — see the hub.
• If you do supplement, pick the lowest dose you can find. Even the 6–10mg products ranked on this site are 2.6–5.6x the AI; don't reach for a higher-mg bottle assuming "more is better" — this is a U-shaped nutrient.
• Don't stack manganese sources. If you take a multivitamin or bone formula that already includes manganese, adding a standalone product can push you toward or past the UL without you realizing it.
• Liver disease or long-term parenteral/enteral nutrition? Do not self-supplement manganese — this is a hard clinical-management situation, not a dosing question.
• Concerned about well water? Test it — private/unregulated wells can carry naturally elevated manganese, a real and underrecognized exposure pathway separate from diet or supplements.

Frequently asked questions

Related

• Manganese: what it is & who actually might need it
• Best manganese — ranked by cost per elemental mg, plus which products to avoid
• Manganism — the full occupational, water, and liver-disease/TPN breakdown
• Calcium dosage guide — the other half of the bone-formula interaction

Sources